Overview

RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
RIvaroxaban for Valvular heart diseasE and atRial fibrillation trial (RIVER trial).
Phase:
Phase 2
Details
Lead Sponsor:
Hospital do Coracao
Treatments:
Rivaroxaban
Warfarin